Your Fibromyalgia Isn't in Your Head. Your Genes Might Be.

Your COMT gene produces an enzyme that clears dopamine, norepinephrine, and epinephrine from your brain and nervous system. Think of it as your internal cleanup crew for stress hormones. When it’s working well, stress hormones rise briefly and then get cleared. Your nervous system returns to calm.

The Val158Met variant, carried by roughly 25% of the population in slow form, slows this cleanup process significantly. If you have the slow variant, stress hormones linger in your nervous system longer than they should. Dopamine stays elevated. Norepinephrine keeps your pain amplification circuits turned on. Your nervous system stays in a state of sympathetic overdrive.

For people with fibromyalgia and the slow COMT variant, this means persistent hyperarousal. Your pain threshold doesn’t recover between stressors. Background pain feels sharper. Caffeine, stimulants, and high stress don’t just make you jittery; they amplify pain signals throughout your body. You feel pain more intensely because your nervous system is biochemically stuck in alert mode.

Your SLC6A4 gene produces the serotonin transporter, a protein that recycles serotonin back into neurons after it’s been released. Serotonin is your nervous system’s pain-dampening neurotransmitter. Without efficient recycling, serotonin levels drop and pain signaling intensifies.

The 5-HTTLPR short allele, present in roughly 40% of the population, reduces how efficiently serotonin gets recycled. You end up with chronically lower serotonin availability, even if you eat enough tryptophan or take a precursor. Your brain simply isn’t retaining the serotonin it produces. This creates a state of serotonergic deficit that amplifies pain perception throughout your body.

With the short allele, your fibromyalgia pain is typically worse in the morning when serotonin is naturally lowest. Stress depletes serotonin faster, worsening pain for days after emotional triggers. You may find that depression or anxiety accompanies your pain because the same serotonin deficit drives both. Standard SSRIs sometimes help, but not always, because the problem is reuptake efficiency, not just baseline production.

Your MTHFR gene produces methylenetetrahydrofolate reductase, an enzyme that converts dietary folate into methylfolate, the active form your nervous system needs. Methylfolate is a cofactor in the synthesis of all your pain-modulating neurotransmitters: serotonin, dopamine, and norepinephrine. It also helps manage homocysteine, an inflammatory marker that can worsen pain signaling.

The C677T variant, present in roughly 40% of people of European ancestry, reduces MTHFR enzyme activity by 40-70%. Even if you eat folate-rich foods, your cells cannot convert it efficiently into the active form your nervous system needs. You develop a functional folate deficiency that specifically impairs neurotransmitter synthesis. Your brain cannot manufacture adequate serotonin, dopamine, or norepinephrine, no matter how hard your other enzymes work.

For fibromyalgia, this manifests as pain that doesn’t respond to serotonin-boosting strategies alone. You feel cognitive fog alongside pain. You may have elevated homocysteine even with normal B vitamins on standard blood tests. Your pain is worse when you’re under methyl-demand stress (pregnancy, illness, intense work). You may have noticed that folic acid supplements don’t help, but you haven’t tried the active form.

Your BDNF gene produces brain-derived neurotrophic factor, a protein that supports the growth and survival of pain-processing neurons in your central nervous system. BDNF also regulates neuroplasticity, your brain’s ability to rewire and adapt. In chronic pain states, BDNF is a double-edged sword: you need it for healing, but overexpression drives central sensitization.

The Val66Met variant, carried by roughly 30% of the population, reduces how much BDNF is secreted in response to activity and stress. This impairs your nervous system’s ability to adapt to pain signals and downregulate pain circuits. Instead of your brain learning to ignore background noise, it keeps amplifying it. Central sensitization becomes more entrenched rather than resolving.

With the Met allele, your fibromyalgia pain may worsen over time if untreated because your nervous system isn’t naturally rewiring toward pain reduction. Exercise and behavioral techniques help less than they do in people with better BDNF signaling. You may have noticed that standard physical therapy made your pain worse, not better. Your nervous system needed pain suppression first, not nervous system stimulation.

Your OPRM1 gene produces the mu-opioid receptor, the protein that responds to your body’s own endogenous opioids: endorphins and enkephalins. These are your natural pain-relief system. When your body detects pain or stress, it releases endogenous opioids that bind to this receptor and reduce pain signaling. Your OPRM1 determines how sensitive this receptor is.

The A118G variant, carried by roughly 10-15% of people of European ancestry, reduces how effectively endogenous opioids bind to the receptor. You have a naturally diminished endogenous opioid response. Your body can produce normal amounts of endorphins and enkephalins, but they don’t relieve pain as effectively as they should. Your pain threshold is lower. Your natural pain suppression is weaker.

With the G allele, your fibromyalgia pain feels more intractable because you have genuinely less endogenous pain relief. Standard opioid medications often don’t help much, or require higher doses, because your receptor is less responsive. But this also means that low-dose naltrexone (LDN) a medication that blocks the receptor briefly to upregulate endogenous opioid production, often works dramatically well for you because it essentially forces your body to make more of its own pain relief.

Your TRPV1 gene produces a pain receptor found on nerve endings throughout your body. This receptor detects heat, capsaicin (from chili peppers), and chemical pain signals. It’s your body’s way of saying something is dangerously hot or chemically irritating. When functioning normally, TRPV1 fires only when there’s actual danger: temperature above 109F, real chemical irritation, tissue damage.

Gain-of-function variants in TRPV1, present in roughly 25-30% of the population, lower the threshold at which this receptor fires. Your pain receptors activate at lower temperatures, lower chemical concentrations, and with lighter pressure than they should. Touch that would normally feel neutral feels painful. Room temperature feels too warm on your skin. Certain foods (spicy, acidic) cause burning in your mouth and throat even in mild amounts.

With TRPV1 gain-of-function variants, your fibromyalgia typically includes allodynia: pain from stimuli that normally don’t cause pain. Light touch to your arms or legs hurts. Tags in clothing become intolerable. You feel burning sensations without obvious inflammation. Temperature sensitivity is pronounced. This isn’t psychological; your pain receptors are literally more excitable at the molecular level.